Results 151 to 160 of about 466,856 (291)

Ophthalmol Glaucoma [PDF]

open access: yes
Purpose:To assess the efficacy of the Support, Educate, Empower (SEE) glaucoma coaching program on medication adherence among poorly adherent glaucoma patients for 12 months following cessation of the intervention.Design:Uncontrolled intervention study ...

core  

A prospective randomised comparison of two different stenting sutures when using the Baerveldt 101–350 aqueous shunt – Lab transition to clinical process

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The Baerveldt glaucoma drainage implant (BGI 101–350) is one of the most effective treatment options for managing refractory glaucoma. To mitigate early hypotony in non‐valved implants, intraluminal occluding sutures (IOSs) are commonly used.
Evripidis Sykakis   +7 more
wiley   +1 more source

Comparison of Medication Adherence Assessment Tools to Identify Glaucoma Medication Nonadherence. [PDF]

open access: yesOphthalmol Glaucoma, 2022
Cho J   +6 more
europepmc   +1 more source

Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops

open access: yes, 2013
Lauren M Rosin,1 Nicholas P Bell1,2 1Ruiz Department of Ophthalmology and Visual Science, The University of Texas Medical School at Houston, 2Robert Cizik Eye Clinic, Houston, TX, USA Abstract: Timolol (generic name) is a frequently used medication for ...
Bell NP, Rosin LM
core  

Vision‐related quality of life following trabeculectomy versus Baerveldt glaucoma implant: Five‐year results from a randomized clinical trial

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To assess the vision‐related quality of life (VRQoL) in glaucoma patients over 5 years after primary Baerveldt glaucoma implant (BGI) or trabeculectomy (TE) using a secondary analysis of a randomized clinical trial. Methods Patients were randomized to undergo TE or receive a BGI.
Ionela Popescu‐Giovanitsas   +4 more
wiley   +1 more source

Effects of Glaucoma Medication on Dry Eye Syndrome and Quality of Life in Patients with Glaucoma. [PDF]

open access: yesKorean J Ophthalmol, 2021
Maeng KJ   +8 more
europepmc   +1 more source

Longitudinal changes in bleb morphology following the PAUL Glaucoma Implant visualized using ultrasonography

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To evaluate bleb morphology longitudinally using sonography following glaucoma drainage device (GDD) surgery. Methods Prospective observational cohort study conducted from January 2022 to March 2024, with follow‐up up to 12 months postoperatively. Bleb morphology, including superior and inferior bleb height, transverse and longitudinal
Constance Liegl   +9 more
wiley   +1 more source

Review of glaucoma medication adherence monitoring in the digital health era. [PDF]

open access: yesBr J Ophthalmol, 2023
Erras A   +3 more
europepmc   +1 more source

Chlorhexidine 0.02% or polyhexamethylene biguanide 0.02% as the main treatment for Acanthamoeba keratitis

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To report medical cure and treatment failure rates of Acanthamoeba keratitis (AK) with respect to type of treatment, disease stage and prognostic factors. Methods Electronic records were reviewed for 45 patients with PCR‐positive AK treated at the Department of Ophthalmology, Aarhus University Hospital, Denmark from 2012 to 2025 ...
Anders Ivarsen   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy